When was GenomSys founded?

GenomSys was founded in 2015 and raised its 1st funding round 3 years after it was founded.

Where is GenomSys located?

GenomSys is headquartered in Lausanne, Switzerland.

How many employees does GenomSys have?

As of Apr 30, 2026, the latest employee count at GenomSys is 6.

Is GenomSys a funded company?

GenomSys is a funded company, having raised a total of $9.35M across 3 funding rounds to date. The company's 1st funding round was a $***** Grant (prize money) round, raised on Jul 01, 2018.

When was the latest funding round of GenomSys?

GenomSys' latest funding was a $***** Series A round on Sep 18, 2019, with participation from 3 investors. Its primary sector is Life Sciences Tech. In Switzerland, the Life Sciences Tech sector has seen $18.3M in funding in 2026 to date.

Where does GenomSys rank among its competitors?

GenomSys ranks 57th amongst 451 active competitors, of which 83 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was SeqOne, which secured $22.7M in May, 2025.

Who are the top competitors of GenomSys?

GenomSys' top competitors include DNAnexus, Twin Strand Bio and Deep Genomics. Among them, SeqOne secured the most recent funding round in May, 2025.

GenomSys - 2026 Company Profile, Funding & Competitors

Company Details

GenomSys develops technology for the efficient compression, storage, transport and manipulation of genomic data. The company has collaborations with nearly all of the top genomics research centers in Europe and America to develop and deploy their solutions.

Website: genomsys.com
Social

Key Metrics

Founded Year

2015

Location

Lausanne, Switzerland

Stage

Series A

Total Funding

$9.35M in 3 rounds

Latest Funding Round

Series A, Sep 18, 2019, $*****

Investors

Preon Capital & 4 more

Ranked

57^th among 451 active competitors

Employee Count

6 as on Apr 30, 2026

Similar Companies

DNAnexus & 621 more

View GenomSys' full profile

GenomSys has raised a total funding of $9.35M over 3 rounds. Its first funding round was on Jul 01, 2018. Its latest funding round was a Series A round on Sep 18, 2019 for $*****. 3 investors participated in its latest round. GenomSys has 5 institutional investors.

Here is the list of recent funding rounds of GenomSys:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Sep 18, 2019	4432013	Series A	8285620	7248315	4847948	1983560
Dec 31, 2018	9562056	Grant (prize money)	3451163	4726810	4572176	EIC Fund
Jul 01, 2018	1922128	Grant (prize money)	6533741	8792051	7166332	Europa

Access funding benchmarks and valuations. Sign up today!

View details of GenomSys's funding rounds and investors

GenomSys' employee count trend

GenomSys has 6 employees as of Apr 26. Here is GenomSys's employee count trend over the years:

Uncover GenomSys' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of GenomSys include DNAnexus, Twin Strand Bio and Deep Genomics. Here is the list of Top 10 competitors of GenomSys, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	DNAnexus 2009, Mountain View (United States), Series H	Provider of cloud-based genome informatics & data management platform	$473M	Google Ventures, TPG & 21 others	70/100
2nd	Twin Strand Bio 2015, Seattle (United States), Series B	Developer of DNA sequencing technology to identify genomic mutations	$84M	Madrona, S32 & 9 others	65/100
3rd	Deep Genomics 2014, Toronto (Canada), Series C	AI-powered platform for RNA biology to accelerate genetic therapy discovery	$238M	SoftBank Vision Fund, Khosla Ventures & 16 others	63/100
4th	Hexagon Bio 2017, Menlo Park (United States), Series B	Provider of bioinformatics tools for the analysis of microbial genomic sequencing data	$206M	The Column Group, Nextech Invest & 10 others	63/100
5th	Genomenon 2014, Ann Arbor (United States), Series B	Provider of software, data, and services for genomic information analysis	$36.8M	Michigan Rise, Spring Mountain Capital & 19 others	58/100
6th	BC Platforms 1997, Zurich (Switzerland), Series D	Provider of a platforms for genomic data analysis and management	$47.1M	Tesi, Debiopharm & 6 others	58/100
7th	SeqOne 2017, Montpellier (France), Series A	Provider of bioinformatics tools for the analysis of genome sequencing data	$48.8M	Elaia, Supernova Invest & 7 others	58/100
8th	Molecular Health 2004, Heidelberg (Germany), Late Stage	Genomic software solutions for healthcare providers	$26.9M	Dievini, The University of Texas at Austin ... & 1 others	56/100
9th	Fabric Genomics 2009, Oakland (United States), Acquired	AI-based disease diagnosis and genomic analysis tool for providers	$32.8M	UPMC, Artis Ventures & 12 others	55/100
10th	Linus Biotechnology 2020, New York City (United States), Series A	Developer of diagnostic tests for central nervous system and gastrointestinal disorders	$47.6M	GreatPoint Ventures, Bow Capital & 3 others	55/100
57th	GenomSys 2015, Lausanne (Switzerland), Series A	Provider of solutions and systems for efficient genomic information processing	$9.35M	Dolby Family Ventures, Elysia Capital & 3 others	38/100